The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury (Q37926558)

25 August 2017

1 reference

title

The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury (English)

1 reference

25 August 2017

1 reference

Yumei Ye

1

1 reference

25 August 2017

Jose R Perez-Polo

series ordinal

2

1 reference

25 August 2017

David Aguilar

series ordinal

3

1 reference

25 August 2017

Yochai Birnbaum

series ordinal

4

1 reference

25 August 2017

4 September 2011

1 reference

Basic Research in Cardiology

25 August 2017

1 reference

25 August 2017

106

1 reference

25 August 2017

925-952

1 reference

25 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00395-011-0216-6

25 August 2017

0 references

cites work

Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

AMP-activated protein kinase in the heart: role during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Loss of cardioprotection with ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Mechanisms of action of glucagon-like peptide 1 in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Sarcolemmal K(ATP) channels: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

KATP channels and myocardial preconditioning: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Survival kinases in ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The in-situ pig heart with regional ischemia/reperfusion - ready for translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth fac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Heat stress-induced protection of endothelial function against ischaemic injury is abolished by ATP-sensitive potassium channel blockade in the isolated rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Resistance to myocardial infarction induced by heat stress and the effect of ATP-sensitive potassium channel blockade in the rat isolated heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotection by metformin is abolished by a nitric oxide synthase inhibitor in ischemic rabbit hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The PPAR-gamma agonist rosiglitazone facilitates Akt rephosphorylation and inhibits apoptosis in cardiomyocytes during hypoxia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Acute alcohol-induced protection against infarction in rabbit hearts: differences from and similarities to ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Troglitazone inhibits type 2KATP channel activity and depolarises tolbutamide-sensitive neurones in the rat ventromedial hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Impairment of myocardial protection in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Troglitazone administration limits infarct size by reduced phosphorylation of canine myocardial connexin43 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Metformin improves cardiac functional recovery after ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Effects of pharmacological modulation of the ATP-sensitive potassium channels on the development of warm-up angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischaemic preconditioning and TNF-alpha-mediated preconditioning is associated with a differential cPLA2 translocation pattern in early ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Myocardial K(ATP) channels in preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Control of cardiovascular differentiation by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardiac regulation by phosphoinositide 3-kinases and PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Activation of ATP‐dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischemic postconditioning in pigs: no causal role for RISK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischemic postconditioning: experimental models and protocol algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Metformin induces cardioprotection against ischaemia/reperfusion injury in the rat heart 24 hours after administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Troglitazone but not pioglitazone affects ATP-sensitive K(+) channel activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Isoflurane-induced preconditioning is attenuated by diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Simvastatin-induced myocardial protection against ischemia-reperfusion injury is mediated by activation of ATP-sensitive K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Preconditioning the diabetic heart: the importance of Akt phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-011-0216-6

10.1007/S00395-011-0216-6

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference